Important Announcements

ACL Laboratories continuously strives to provide the best laboratory services possible. Our Test Bulletins and Important Announcements include information regarding new test offerings, changes in test procedures, reference range changes, or modifications in specimen collection protocol and/or new specimen collection devices.

aug. 05, 2020

ACL Laboratories Discontinues In-House Testing for Viral Loads

Effective immediately, ACL Laboratories has discontinued in-house testing for the following tests: • BKV Quantitative by PCR (BKVQN) • BKV Quantitative by PCR, Urine (UKVQN) • CMV Quantitative by PCR (CMVQN) • EBV Quantitative by PCR (EBVQN) • Blood Viral Panel Quantitative by PCR (BVPQN) The reagent needed for these … Read more

jul. 23, 2020

2020 Annual Physicians Report

ACL Laboratories maintains an active compliance program that reflects our commitment to conduct business in compliance with all federal, state and local laws. As a participant in federally funded health care programs, ACL Laboratories is required by the Office of Inspector General (OIG) and the US Department of Justice (DOJ) … Read more

jul. 08, 2020

ACL Laboratories Revises SwabOne Testing Menu

Effective Thursday, July 16, 2020, ACL Laboratories will update the Women’s Health SwabOne™ testing menu for vaginal pathogens. Read more

may. 14, 2020

ACL Offers Blood/Serology Testing for COVID-19

ACL Laboratories Offers Blood/Serology Testing for COVID-19 Read more

jan. 28, 2020

Important Announcement Novel Coronavirus Jan 2020

Background A cluster of pneumonia cases was first identified in Wuhan, China in December 2019. The causative agent of cases was later identified as a novel coronavirus that is currently being referred to as 2019-nCoV. It has also been referred to as Wuhan Virus. Within a matter of weeks, the … Read more